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BASELINE DEPRESSION LEVELS DO NOT AFFECT
EFFICACY OF COGNITIVE-BEHAVIORAL SELF-HELP
TREATMENT FOR INSOMNIA
Jaap Lancee, Ph.D.,1,2∗ Jan van den Bout, Ph.D.,1 Annemieke van Straten, Ph.D.,3 and
Victor I. Spoormaker, Ph.D.4
Background:Cognitive-behavioral therapy can effectively treat insomnia (CBT-
I). Randomized controlled trials have shown efficacy of self-help CBT-I, but un-
clear is whether excluding depressive patients boosted treatment effects.Method:
We administered unsupported self-help CBT-I to insomnia patients with low
and high depression levels. Based on the validated Centre of Epidemiological
Studies-Depression (CES-D) scale, the internet-recruited sample (N = 479) was
divided into three groups: low depression scores (n = 198), mild depression scores
(n = 182), and high depression scores (n = 99). Follow-ups were 4 and 18 weeks
after completion of the treatment. Results: At 4-week follow-up, all groups had
a similar amelioration on the primary sleep measures (d = 0.1–0.7; P < 0.05)
and the secondary insomnia ratings (d = 1.2; P < 0.001). The only difference
was that the high/mild depression groups had a steeper reduction in depression
(d = 1.0–1.1; P < 0.001) and anxiety scores (d = 0.7–0.8; P < 0.001) than
the low depression group (depression and anxiety: d = 0.3; P < 0.01), possibly
due to floor effects in the latter group. The observed effects were sustained at
the 18-week follow-up. Conclusions: This study showed that CBT-I is effective
regardless of baseline depression levels. Treating the combination of insomnia
and depression is an extra challenge since it is associated with increased sleep
problems. These data may help us understand the relationship between insomnia
and depression and indicate that self-help CBT-I may be a promising addition to
regular depression treatment. Depression and Anxiety 30:149–156, 2013. C©
2012 Wiley Periodicals, Inc.
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INTRODUCTION
Insomnia is a common disorder that is characterized
by having trouble falling asleep, maintaining sleep, and
feeling tired during the day. For chronic insomnia, com-
plaints have to persist for at least a month.[1] Impaired
sleep causes fatigue and distress.[2–4] Insomnia is asso-
ciated with psychological problems such as anxiety and
depression.[5,6]
Cognitive-behavioral therapy can effectively treat in-
somnia (CBT-I),[7–11] but current waiting lists may
only be shortened by less intensive approaches such
as self-help therapy.[12] A meta-analysis found small-
to-moderate effects of self-help CBT-I on subjec-
tive insomnia complaints.[13] More recently, several
studies[14–17] observed larger effects on subjective sleep
measures and insomnia complaints. One study[15] also
found that therapist support boosted these effects.
C© 2012 Wiley Periodicals, Inc.
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In our previous study,[16] we compared unsupported
self-help CBT-I delivered through the internet with un-
supported self-help delivered through written materials.
We found that both self-help treatments generated large
effects compared to a waiting list on global insomnia
measures and moderate effect on subjective sleep mea-
sures. However, in our study[16] and in many other self-
help treatment studies (e.g. [14,18]) insomnia patientswith
high depression or major psychiatric disorders were ex-
cluded.
Our reason for this exclusion was that depression may
interact with treatment motivation, adherence, and ef-
ﬁcacy. This opened the possibility that the large effects
may partly be attributed to the exclusion of subjects with
high depression scores. This would suggest that CBT-
I is more effective, or more appropriate, for insomnia
patients without co-morbid depression. That would be
unfortunate since several studies found a strong rela-
tionship between insomnia and depression.[5,6, 19–21] In-
somnia can be a predictor of developing depression; a
recent meta-analysis reported that nondepressed peo-
ple with insomnia had a twofold risk of developing
depression.[22] Moreover, insomnia is a frequent resid-
ual symptom of depression treatment.[23–25] This in-
dicates that insomnia is not just a frequent symptom
in depression but potentially a separate sleep disor-
der that exacerbates major depressive disorder. Spe-
ciﬁc treatment of insomnia during CBT for depression
(that typically does not focus on sleep) may therefore
be beneﬁcial to depression as well—if CBT-I is equally
effective for insomnia patients with high depression
levels.
There is evidence that face-to-face CBT-I is equally
effective for insomnia patients with low and high depres-
sion levels.[26,27] Studies employing face-to-face ther-
apy demonstrated that CBT-I for depressed patients can
have an additional effect to medication[28] and that it
can help in residual depression.[29] Moreover, one pi-
lot study found promising effects of self-help CBT-I for
depressed patients with insomnia.[30] Another study[15]
observed positive effects of self-help CBT-I in a group
with heterogeneous co-morbid disorders and concluded
that depression at baseline was not signiﬁcantly related
to level of improvement. The authors argued that stud-
ies addressing the effect of CBT-I on speciﬁc co-morbid
disorders are much needed.[15] If self-help CBT-I is in-
deed beneﬁcial for insomnia patients with high depres-
sion scores, this may help improve treatment for depres-
sion as self-help CBT-I can easily be added to standard
therapy.
The current study investigated the efﬁcacy of unsup-
ported self-help CBT-I in a sample that was stratiﬁed by
baseline Centre of Epidemiological Studies-Depression
scale (CES-D) depression scores following guidelines of
Zich et al.[23] We expected that insomnia patients beneﬁt
equally from self-help CBT-I regardless of their depres-
sion score.
MATERIALS AND METHODS
PARTICIPANTS
Inclusion criteria were lying awake at least 30 min a night at least
three nights a week, having insomnia disorder according the SLEEP-
50 (cut off ≥ 19[31]) and the Insomnia Severity Index (ISI; which was
ﬁlled out after the SLEEP-50; cutoff > 7[32]), being 18 years or older,
and having a valid e-mail address. Exclusion criteria were sleep apnea
(cut off ≥ 15[31]); more than three glasses of alcohol a day for at least
21 days a month, marihuana use more than once a week, schizophre-
nia/psychosis, and current suicidal plans (thus, people with suicidal
ideation were not excluded; see Table S1 for the speciﬁc questions).
We did not exclude on bipolar disorder speciﬁcally.
Seven hundred and ninety persons started the online questionnaire,
181 did not complete the baseline assessment, 55 did notmeet inclusion
criteria, four were considered outliers (see statistical analysis), and 127
were excluded from the study due to reasons mentioned above (see
Fig. 1 for a ﬂow chart). The ﬁnal sample (N = 479) had a mean age
of 47.0 (SD = 13.6; range = 18–84 years) and included 316 (66.0%)
women (Table 1).
PROCEDURE
The study was in line with the Declaration of Helsinki, approved
by the Medical Ethical Committee of the University Medical Center
Utrecht, and registered at clinicaltrials.gov (ID: NCT01224912). Par-
ticipants were recruited via a popular scientiﬁcDutch insomniawebsite
(www.insomnie.nl). Visitors of this website could ﬁll out the insomnia
scale of the SLEEP-50[31] online. If this test screened positive, people
interested in research participation could leave their e-mail address.
All persons that left their email address in the period from Decem-
ber 2009 to May 2011 were e-mailed by the ﬁrst author with study
information. After completing the online baseline questionnaire, el-
igible participants ﬁlled out an online seven-day diary. After written
informed consent was obtained and the online diary was ﬁlled out,
participants could start their internet-delivered self-help treatment
directly.
Four weeks (4-week follow-up) and 18 weeks (18-week follow-up)
after completion of the 6-week intervention, participants ﬁlled out
online questionnaires and an online 7-day sleep diary. Participants
were considered dropouts after three unanswered reminders (two e-
mails and one postal). The total sample was stratiﬁed into three groups
based on the baseline CES-D scores, following the guidelines by Zich
et al.[23]: low depression scores (score lower than 16; n = 198); mild
depression scores (score between 16 and 27; n = 182); high depression
scores (score of 27 or higher; n = 99; see “Results” for post hoc power
analyses). The mean CES-D score in the current sample was 18.8
(SD = 9.5). In comparison, a trial on internet-delivered treatment for
individuals with symptoms of depression had a mean score of 21.5
(SD ≈ 10.7).[33]
INTERVENTION
The intervention consisted of a 6-week treatment program of ap-
proximately 9,000 words. The intervention comprised a multicompo-
nent approach with the following elements: diary; psycho-education;
relaxation exercises; stimulus control/sleep hygiene; sleep restriction;
challengingmisconceptions about sleep; paradoxical exercise.The self-
help program was also used in our previous study where it is described
more elaborately.[16] No module for sleep medication was included;
participants were advised to contact their general practitioner if they
wanted to quit sleep medication. In addition, no CBT interventions
for depression were used.
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Figure 1. Flowchart.
The intervention consisted of a simple website that was essentially
digitalized and ﬁtted to a website format. It did not offer interaction
or individual tailoring that is often employed in internet interventions.
E-mail support by a therapist was not offered, but participants had the
opportunity to e-mail the ﬁrst author. In the low depression group,
11 participants asked content-related questions, in the mild depression
group nine, and in the high depression group four (e.g. “Does the website
calculate the sleep restriction window?”; “My bedroom is the only place where
I can study quietly, how can I use this place for sleeping only?”).
MEASUREMENTS
Primary measures—Diary. Participants ﬁlled out a 7-day on-
line diary at baseline and the two follow-up measurements. They
recorded bed time, ﬁnal arising time, sleep onset latency (SOL), num-
ber of nocturnal awakenings (NWAK), and wake after sleep onset
(WASO). From these variables, the time in bed (TIB = ﬁnal aris-
ing time − bed time), total sleep time (TST = TIB − SOL − WASO),
and sleep efﬁciency (SE = (TST/TIB) × 100) were calculated.
Secondary measure—Questionnaire. The following descrip-
tive variables were addressed in the baseline questionnaire: gender,
age, whether one received psychological treatment, took sleep med-
ication, or medication other than for sleeping, and if they perceived
their insomnia to be due to a physical condition.
Insomnia complaints were measured by the Insomnia Severity In-
dex (ISI). The questionnaire uses a 5-point Likert scale (e.g. 0 = no
problem to 4 = very severe problem; total score range = 0–28) and
is a valid and reliable measure to detect changes in insomnia severity
(internal consistency= 0.78).[32,34] A change of eight points or greater
is suggested as a clinical meaningful change.[35] A cut-off of seven is
used to determine insomnia.
Depression was measured by a Dutch translation of the 20-item
CES-D.[36,37] This scale has good internal consistency (α = 0.79–
0.92; test–retest correlation is 0.90). Zich et al.[23] suggested 16 as the
TABLE 1. Demographic characteristics of participants per group
Low Mild High
depression depression depression
(n = 198) (n = 182) (n = 99)
Mean age (SD) 50.8 (13.9) 44.87 (12.5) 43.1 (12.9) F (2, 478) = 15.0 P < 0.001
n % n % n %
Gender Male 81 40.9 63 34.6 19 19.2 χ2 (2) = 13.9 P = 0.001
Female 117 59.1 119 65.4 80 80.8
Prescribed sleep No 134 67.7 124 68.1 61 61.6 χ2 (2) = 1.40 P = 0.50
medication* Yes 64 32.3 58 31.9 38 38.4
Medication other than No 189 95.5 165 90.7 80 80.8 χ2 (2) = 16.6 P < 0.001
for sleeping** Yes 9 4.5 17 9.3 19 19.2
In psychological No 181 91.4 158 86.8 34 34.3 χ2 (2) = 34.5 P < 0.001
treatment Yes 17 8.6 24 13.2 65 65.7
Insomnia due to a No 173 87.4 157 86.3 87 87.9 χ2 (2) = 0.18 P = 0.92
physical condition Yes 25 12.6 25 13.7 12 12.1
* = Weekly usage as measured by sleep diary; ** = Psychopharmacological medication other than for sleeping
Depression groups are based on CES-D indication not on clinical diagnosis.
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standard cutoff and 27 as the stringent cutoff. In the current study, this
resulted in the following groups: low depression scores (score lower
than 16); mild depression scores (score between 16 and 27); high de-
pression scores (score of 27 or higher). In the current sample, the
CES-D had an internal consistency of α = 0.90, a correlation of r =
0.43 (P < 0.001) with the Insomnia Severity Index, and r = 0.01 (P =
0.92) with sleep efﬁciency in the diary.
Anxiety was measured by the Dutch version of the seven anxiety
items of the Hospital Anxiety and Depression Scale (HADS).[38] The
reliability of theHADS is good (α = 0.80–0.84), and so is the test–retest
correlation (0.89; P < 0.001).
At 4-week follow-up, participants rated the seven modules of the
self-help intervention on a Likert scale on whether they completed
the exercises (1 = not completed to 5 = fully completed). Modules
were considered completed if they were rated a four or above. Partici-
pants adhered to the intervention if they completed at least half of the
modules (four or more).
STATISTICAL ANALYSIS
To test for time and interaction effects (time × group), a mul-
tilevel regression analysis was conducted. Multilevel regression is
an intention-to-treat procedure that allows participants with only
one measurement in the analyses.[39] A logistic regression anal-
ysis was performed for each group to evaluate variables that
were associated with both questionnaire and diary nonresponse. If
these variables correlated with the dependent variables, they were
taken into account by adding them as covariates in the multilevel
analysis. For the dependent variables, depression and anxiety no
time × group interaction analyses were conducted because of the
large baseline differences (Table 2). Four participants were excluded
from the analysis because they were considered outliers (z-score >
|3.29| on baseline sleep efﬁciency; one in the “low,” two in the “mild,”
and one in the “high” depression group). Cohen’s ds were calcu-
lated on the observed data with (Mpre1 − Mpost1)/σ pooled. A sig-
niﬁcance level of P < 0.05 (two sided) was used throughout the
study.
We also imputed the missing post-test values with multiple im-
putation to test whether attrition inﬂuenced the follow-up scores.[40]
However, multiple imputation is based on the “missing at random”
assumption and this might be too liberal since attrition might be
correlated to cases of failed or less effective treatment. Therefore,
we included these ﬁles as a comparison in Supporting Information
(Table S2).
TABLE 2. Observed pre- and posttreatment means and standard deviations with corresponding Cohen’s d for high,
mild, and low depression groups
Pretreatment 4-week follow-up 18-week follow-up
M (SD) M (SD) d M (SD) d
Primary measures Diary
SE (%) Low depression 72.95 (10.90) 80.60 (10.10) 0.73*** 80.81 (11.77) 0.69***
Mild depression 72.12 (12.98) 78.43 (15.40) 0.44*** 78.78 (13.99) 0.49***
High depression 72.82 (12.37) 80.21 (10.72) 0.64*** 82.29 (8.16) 0.90***
TST Low depression 360.7 (62.17) 388.9 (61.00) 0.46*** 387.9 (65.25) 0.43***
(minutes) Mild depression 365.7 (72.77) 394.2 (90.18) 0.35*** 392.2 (81.08) 0.34***
High depression 380.6 (80.18) 406.5 (78.20) 0.33*** 418.9 (67.05) 0.52***
SOL Low depression 53.13 (35.38) 36.42 (28.12) 0.52*** 35.46 (28.69) 0.55***
(minutes) Mild depression 58.50 (44.02) 47.37 (46.46) 0.25*** 46.36 (54.11) 0.25***
High depression 65.11 (42.93) 42.03 (26.91) 0.64*** 39.52 (31.26) 0.68***
WASO Low depression 80.87 (49.99) 56.81 (35.52) 0.55*** 57.37 (42.41) 0.51***
(minutes) Mild depression 83.78 (55.78) 60.94 (52.93) 0.42*** 60.91 (48.12) 0.44***
High depression 77.64 (55.09) 56.39 (44.71) 0.42*** 57.30 (43.13) 0.41***
NWAK Low depression 2.68 (2.11) 2.20 (1.37) 0.27*** 2.21 (1.60) 0.25***
Mild depression 2.80 (3.08) 2.39 (3.38) 0.13*** 2.07 (1.30) 0.31***
High depression 2.67 (1.54) 2.36 (1.58) 0.20* 2.19 (1.47) 0.32*
Secondary measures Questionnaire
Insomnia Low depression 16.73 (3.52) 11.63 (5.13) 1.16*** 11.01 (5.14) 1.30***
(ISI) Mild depression 18.63 (3.56) 12.72 (5.65) 1.25*** 12.44 (5.45) 1.34***
High depression 20.69 (3.60) 14.23 (6.65) 1.21*** 12.67 (7.18) 1.41***
Depression Low depression 10.09 (3.76) 8.45 (6.06) 0.33** 8.28 (5.63) 0.38**
(CES-D) Mild depression 20.55 (2.97) 15.15 (8.13) 0.88*** 13.64 (6.55) 1.36***
High depression 33.17 (5.49) 23.83 (11.55) 1.03*** 22.16 (11.28) 1.24***
Anxiety Low depression 4.91 (2.74) 4.12 (3.08) 0.27** 3.86 (2.62) 0.39***
(HADS) Mild depression 8.26 (3.39) 5.94 (3.31) 0.69*** 5.97 (3.17) 0.70***
High depression 11.67 (3.31) 8.77 (4.37) 0.75*** 7.84 (4.10) 1.03***
Signiﬁcance levels were calculated using multilevel regression; *P < 0.05; **P < 0.01; ***P < 0.001 (two sided). See Table S2 and S3 for the multilevel
regression analyses and the imputed follow-up means and Cohen’s d effect sizes. Depression groups are based on CES-D indication not on clinical
diagnosis. SE, sleep efﬁciency; TST, total sleep time; SOL, sleep onset latency; WASO, wake after sleep onset; NWAK, number of nocturnal
awakenings.
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RESULTS
BASELINE DIFFERENCES AMONG GROUPS
At baseline, we observed signiﬁcant differences among
groups for ISI insomnia rating (F (2, 478) = 42.4, P <
0.001), anxiety (F (2, 478) = 161.8, P < 0.001), and de-
pression (F (2, 478) = 1168, P < 0.001; Table 2). There
were also baseline differences for gender, age, medica-
tion, and being in treatment (Table 1).
NONRESPONSE
Response rates to the questionnaire and the diary are
depicted in the ﬂow chart (Fig. 1). At 4-week follow-
up, there was no signiﬁcant difference in nonresponse
on the diary and questionnaire among the low, mild,
and high depression groups (P > 0.05). Furthermore,
in the mild (P = 0.03) and high (P = 0.01) depression
group, completing the questionnaire was associated with
high age. In addition, in the mild depression group, high
NWAKwas associated with increased completion of the
pretreatment diary (P = 0.01).
At 18-week follow-up, there was a marginally signif-
icant difference in nonresponse on the questionnaire
among the groups (P = 0.08). In the low depression
group, gender (P = 0.03) was associated with completing
the questionnaire and low SOL (P = 0.045) with com-
pleting the diary. In the mild depression group, high
WASO was associated with completing the diary (P =
0.02).
COMPLETION OF THE MODULES
No statistical differences were found among the three
groups in completion rates (P > 0.05). In the low depres-
sion group, participants that ﬁlled out the 4-week follow-
upquestionnaire, completed on average 3.83 (SD= 2.43)
out of seven modules and 89 (62.2%) adhered to the in-
tervention. In the mild depression group, participants
completed on average 3.78 (SD = 2.32) modules and
78 (57.4%) adhered to the intervention. In the high de-
pression group, participants completed on average 3.79
(SD = 2.15) modules and 39 (54.9%) adhered to the in-
tervention (two scores were missing).
POWER
Post hoc, a power calculation was performed using
G*power 3.1. In G*power 3.1., the effect size “f” is used
for a repeated measurements design.[41] For the power
calculation, we assumed all groups had as much 4-week
follow-up diary responders as the high depression group
(n = 47). This is a conservative estimate since more par-
ticipants completed the questionnaire, the other groups
had alsomore responders on the diary, and themultilevel
regression analyses takes all baseline measurements into
account; the actual power is thus likely higher. Based on
three groups with a 4-week follow-up, sample size of n =
47, an α level of 0.5 (two sided), and a repeated measure
time× group interaction, we achieved a power of 1.00 to
detect a medium effect size (f = 0.25) and a power 0.55
to detect a small effect size (f = 0.10).
EFFECTIVENESS OF THE SELF-HELP
TREATMENT
At 4-week follow-up, all groups showed within group
effects on all primary (diary) and secondary (question-
naire) measures (P < 0.05; Table 2). Multilevel regres-
sion analyses showed no signiﬁcant time × group inter-
action effect among groups on ISI insomnia rating, SE,
TST, SOL, WASO, and NWAK (P > 0.05; Fig. 2).
At 18-week follow-up, the effects were sustained. In
addition, on SOL (P < 0.05) and the ISI (P < 0.01) we
observed a signiﬁcant interaction effect for the high de-
pression group compared to the mild (SOL: b = −12.74;
SE = 5.04; ISI: b = −1.83; SE = 0.79) and low group
(SOL: b = 10.21; SE = 4.91; ISI: b = –2.14; SE = 0.78).
See Table S2 and S3 for all multilevel regression coef-
ﬁcients and imputed datasets (which rendered roughly
the same results).
There was no signiﬁcant correlation between baseline
depression score and the change score for ISI, SE, TST,
SOL, WASO, and NWAK at 4- and 18-week follow-up
(all r< 0.08; allP> 0.25). For anxiety and depression, we
performed only within-group analyses and no between
group analyses because of the large baseline differences
(see statistical analysis).
CLINICAL CHANGES
Of the participants that completed the 4-week follow-
up, the following percentages achieved a clinical mean-
ingful change on the Insomnia Severity Index (change
≥ 8): low depression: n = 46 (32.2%); mild depression:
n = 47 (34.6%); high depression: n = 25 (36.23%). In the
mild andhighdepressiongroup, about 60%of the partic-
ipants improved to amore favorableCES-Dcutoff score.
In the low/mild depression groups, 10%deteriorated. At
18-week follow-up, we found similar percentages among
the groups. See Table 3 for changes stratiﬁed by group.
ADVERSE EVENTS
Three participants stopped with the treatment be-
cause their sleep problems got worse (one in the mild
and two in the high depression group) and ﬁve stopped
because of a lack of efﬁcacy (two in the low and three in
the mild depression group). A considerable larger por-
tion of the sample did not respond to the follow-ups;
however, only a few provided us with reasons for their
drop out.
DISCUSSION
In this study, participants with high depression scores
at baseline did not react differently to self-help treat-
ment for insomnia than participants with low depression
scores. At 4-week follow-up, we found no differences in
effect among the three groups on the variables of SE,
SOL, WASO, TST, and insomnia rating (ISI). There
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Figure 2. Baseline, 4-week and 18-week follow-up Insomnia Severity Index scores among high, mild, and low depression groups.
TABLE 3. CES-D cutoff score distribution at 4- and
18-week follow-up based on the baseline depression
groups
4-week follow-up
Pretreatment Low Mild High
Low depression n (%) 126 (88.1%) 14 (9.8%) 3 (2.1%)
Mild depression n (%) 79 (58.1%) 44 (32.4%) 13 (9.6%)
High depression n (%) 18 (26.1%) 25 (36.2%) 26 (37.7%)
18-week follow-up
Low Mild High
Low depression n (%) 102 (91.1%) 9 (8.0%) 1 (0.9%)
Mild depression n (%) 66 (67.3%) 28 (28.6%) 4 (4.1%)
High depression n (%) 16 (37.2%) 11 (25.6%) 16 (37.2%)
were baseline differences on ISI insomnia rating, but
in all groups insomnia was ameliorated to the same de-
gree (with clinical meaningful changes in 32–34% of the
cases). At 18-week follow-up, the effects were sustained
and we observed a signiﬁcant time × group interaction
effect on SOL and the ISI: the high depression group
improved more than the two other groups. However,
only the SOL difference was observable in Cohen’s d ef-
fect sizes. In general based on these data, depressed pa-
tientswith high depression scores seem to beneﬁt equally
from unsupported self-help CBT-I compared to nonde-
pressed patients.
Another ﬁnding was that in both the mild and high
depression group, the depression scores dropped consid-
erably. About 60% of the participants in the mild/high
depression groups improved to a more favorable cut-
off score (against around 10% that deteriorated in the
low/mild depressiongroups).Theonly difference among
the three groups was that in the current study, partici-
pants in the mild/high depression group improved more
on CES-D/anxiety scores compared to the low depres-
sion group; most likely due to a ﬂoor effect of the latter.
Because of the uncontrolled nature of the study, it
is unsure whether the large improvement on depres-
sion ratings in the mild/high groups can be attributed
to the insomnia self-help treatment. However, previ-
ous research has shown a causal effect of CBT-I on
insomnia and sleep measures[7–11,14,16] and it is known
that insomnia and depression complaints are strongly
correlated,[5,6, 19–21] so a causal effect of CBT-I on de-
pression scores is expected. This study demonstrates
that depression levels do not affect efﬁcacy of CBT-
I and shows a correlation between CBT-I and reduc-
tions in depression scores. This is relevant for the obser-
vation that insomnia is a risk factor for depression[22]
and it supports the notion that insomnia exacerbates
depression.[5,6, 19–21] Furthermore, it suggests that in-
somnia treatment is beneﬁcial for high depression. At
this point, randomized controlled studies that compare
insomnia self-help treatments to valid control groups or
depression-directed treatment would constitute a valu-
able next step.
In general, the effects of this self-help study were
similar to the treatment without support in Jernelo¨v
et al.[15] and to our previous study that delivered unsup-
ported self-help treatment.[16] The effects were smaller
than insomnia self-help treatment with support[15] and
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the trials where sophisticated websites with computer-
ized feedback were used.[14,17] This gives support to
the notion that feedback either computerized or pro-
vided by humans enhances the effectiveness of self-help
treatment.[42]
In addition to the equal effects on outcome measures,
we did not observe any differences regarding nonre-
sponse among the three groups. The generally high non-
response rates are a limitation of this study and stud-
ies evaluating comparable internet-delivered treatment
methodologies. The primary measures had the highest
attrition: at the 4-week follow-up, 53% completed the
diary and 73% completed the questionnaire; even less
completed the 18-week follow-up. To control for this
inﬂuence, we used multilevel regression modeling and
multiple imputation; but even with these state-of-the-
art techniques,[43] the missing values are estimated and
may even lead to inaccurate estimations. Therefore, lim-
iting attrition in future studies is essential.
Furthermore, we divided the groups based on baseline
CES-D scores. This type of depression questionnaire
may have lower validity in an insomnia group because
of the relationship between depression and daytime in-
somnia symptoms (there was a substantial correlation of
r = 0.43 between the CES-D and the ISI on baseline;
however,weobserved that the correlationbetweenCES-
D and SE was not signiﬁcant—r ≈ 0). We did not use
a clinical interview because face-to-face contact might
have contaminated the design. However, by doing so,
we cannot rule out the possibility that the groups should
have been stratiﬁed differently. It would be very helpful
to investigate the cutoffs for the CES-D in an insom-
nia population (as was done for the Beck Depression
Inventory[44]).
Of note is that we decided to exclude patients with
current suicidal plans. Our reason was that an online de-
sign without any face-to-face interaction could not en-
sure their safety. By excluding only patients with suicidal
plans (and not on suicidal ideation), we think we were
able to include the vast majority of the group (only 2
of 790 were excluded). Another issue is the exclusion of
apnea. We used a cutoff score on a questionnaire (sen-
sitivity: 0.85; speciﬁcity 0.88) and this might have led to
false positives.
In short in accordance with previous
studies,[26,27,29,30] this study supports the hypoth-
esis that patients with insomnia and co-morbid
depression can beneﬁt considerably from CBT-I.
This is important because treating the combination of
insomnia and depression constitutes an extra challenge
since it may exacerbate the sleep problems. Of note,
is that the participants in the mild/high depression
groups were not without depressive complaints after
the current treatment and therefore CBT-I should not
be regarded as a replacement of depression-directed
treatment. Therapists might want to consider including
more insomnia directed treatment in their depression
programs. For example, in this study about 30% of the
participants in the high depression group also received
psychological treatment and apparently this treat-
ment did not adequately target insomnia complaints.
A promising option may be to employ a combined
depression–insomnia protocol or an (unsupported)
self-help format for insomnia in an early phase of (face
to face) depression treatment.
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